Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
577
datasets available to search
ShareScore release 0.9.0
Dataset results
577 results for “Growth hormone”
Figure. PCA analysis based on GH-MspI, GH-AluI, PRL, and DGAT1 loci in Turkish native cattle breeds (Turkish Grey - TG, East Anatolian Red - EAR, Anatolian Black - AB, and South Anatolian Red - SAR). in Growth hormone (GH), prolactin (PRL), and diacylglycerol acyltransferase (DGAT1) gene polymorphisms in Turkish native cattle breeds
Figure. PCA analysis based on GH-MspI, GH-AluI, PRL, and DGAT1 loci in Turkish native cattle breeds (Turkish Grey - TG, East Anatolian Red - EAR, Anatolian Black - AB, and South Anatolian Red - SAR).
Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test.
ClinicalTrials.gov study NCT00448747. IPD Sharing: NO. Countries: 1. Publications: 1.
Feather growth rate and hormone deposition vary with elevation but not reproductive costs in resident Mountain Chickadees
Open the record for dataset details and reuse information.
Hormone receptors AR, ER, PR and growth factor receptor Her-2 expression in oral squamous cell carcinoma: Correlation with overall survival, disease-free survival and 10-year survival in a high-risk population
<p>Oral squamous cell carcinoma (OSCC) comprises most of head and neck neoplasms and is one of the highest-ranking and lethal cancers in Pakistan due to prevailing mouth habits. Growth and hormonal receptors act as prognostic markers and targets for therapy in some cancers, but their application in OSCC is largely unexplored. This study aimed to evaluate the expression of growth and hormonal receptors in OSCC patients and correlate it with 10-year, overall and disease-free survival. To achieve this objective, immunohistochemistry for Her-2, AR, ER and PR was performed on 100 formalin-fixed paraffin-embedded primary OSCC specimens. Receptor expression was correlated with mouth habits and clinicopathological features and patient survival was analyzed using Kaplan-Meier method and Cox regression univariate analysis. We observed that in 100 patients, there were 57 males and 43 females. Immunopositive Her-2 expression was observed in 21% of patients, AR in 13%, ER in 3% and 0% for PR. Patients with betel quid/areca nut mouth habits had significantly absent Her-2 expression (P=0.035). Also, Her-2 negative patients were also negative for AR expression (P=0.002). Her-2 positive patients had poor 10-year survival (P=0.041). A trend of low survival and high recurrence rate was observed in AR positive patients, but this was not significant (P=0.072). No statistically relevant correlations were seen in the case of ER and PR. In conclusion, Her-2 may be a valuable marker for predicting long-term prognosis of OSCC patients.</p>
Effect of Short Term Growth Hormone Releasing Hormone in Healthy Men
ClinicalTrials.gov study NCT00850564. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Effects of Growth Hormone Releasing Hormone in HIV
ClinicalTrials.gov study NCT01263717. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With
ClinicalTrials.gov study NCT02616562. IPD Sharing: YES. Countries: 14. Publications: 3.
Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency
ClinicalTrials.gov study NCT03288103. IPD Sharing: NO. Countries: 1. Publications: 2.
Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Appli
ClinicalTrials.gov study NCT01111019. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®
ClinicalTrials.gov study NCT00256126. IPD Sharing: Not stated. Countries: 13. Publications: 4.
Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
ClinicalTrials.gov study NCT00130286. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)
ClinicalTrials.gov study NCT00184717. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Physiologic Growth Hormone Effects in HIV Lipodystrophy
ClinicalTrials.gov study NCT00100698. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese
ClinicalTrials.gov study NCT00675506. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Growth Hormone Therapy for Wasting in Cystic Fibrosis
ClinicalTrials.gov study NCT00803179. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Growth Hormone in a Patient With a Dominant-Negative GHR Mutation
ClinicalTrials.gov study NCT05382637. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive
ClinicalTrials.gov study NCT01491737. IPD Sharing: Not stated. Countries: 8. Publications: 1.
A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood
ClinicalTrials.gov study NCT00212758. IPD Sharing: Not stated. Countries: 1. Publications: 2.
The Effect of Growth Hormone Replacement on Liver Fat
ClinicalTrials.gov study NCT00774579. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
ClinicalTrials.gov study NCT02781727. IPD Sharing: Not stated. Countries: 14. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.